Neuralstem secures patent for stem cell transplantation

09/9/2009 | American City Business Journals

Neuralstem has received a patent for the production and transplantation of neural stem cells for the treatment of nervous system disorders. The company is awaiting a decision from the FDA on its request to start human trials of its stem cell therapies for amyotrophic lateral sclerosis, or Lou Gehrig's disease.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Director, Payer Marketing
Avalere Health
Washington, DC
Actuary
Meridian Health Plan
Detroit, MI
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX